Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

导出 OA

翻译打印收藏纠错

作者： Alessia,Mennitto ^[1] ; Paolo,Grassi ^[1] ; Raffaele,Ratta ^[1] ; Elena,Verzoni ^[1] ; Michele,Prisciandaro ^[1] ; Giuseppe,Procopio ^[2]

作者单位： Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. ^[1] Medical Oncology Unit 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133 Milan, Italy. ^[2]

关键词 immunotherapy nivolumab programmed death-1 renal cell carcinoma

DOI 10.1177/1756287216656811

PMID 27695530

发布时间 2024-05-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览31

Therapeutic advances in urology

2016年8卷5期

319-326页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

Therapeutic advances in urology

相似文献

Therapeutic advances in urology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nivolumab in the treatment of advanced renal cell carcinoma: clinical trial evidence and experience.

Therapeutic advances in urology

相似文献

Therapeutic advances in urology

相关期刊

检索历史清除